. DKK-1 reduced the cell viability of HSC-T6 cells.
Conclusions: Inhibition of Wnt/b-catenin pathway downregulated the TGF-b1-induced activation of HSCs, which might provide us a new therapeutic approach to liver fibrosis.
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Background: To investigate the protective effects of JBP485 (cyclo-trans-4-l-hydroxyprolyl-l-serine, a dipeptide with anti-inflammatory action) on alpha-naphthylisothiocyanate (ANIT)-induced cholestatic hepatitis and whether these are mediated by the organic anion transporters Oat1 and Oat3 and the multidrug resistance-associated protein Mrp2. Methods: The effects of JBP485 on ANIT-induced liver histologic changes, bilirubin (BIL), alanine amiotransferase (ALT), aspartate transaminase (AST), malondialdehyde (MDA), superoxide dismutase (SOD) and myeloperoxidase (MPO) levels were examined. Plasma concentration and cumulative urinary excretion of JBP485 by intravenous administration in vivo, the uptake of JBP485 in kidney slices in vitro were determined by LC-MS-MS. RT-PCR were used for determine Oat1, Oat3 and Mrp2 mRNA. Result: (1) JBP485 decreased BIL, ALT, AST, MDA and MPO levels significantly, alleviated inflammation and necrosis in liver histochemistry in ANIT-treated rats. (2) The plasma concentration of JBP485 was significantly increased, cumulative urinary excretion of JBP485 and the uptake of JBP485 in kidney slices were decreased remarkably. (3) RT-PCR showed the decrease in mRNA of Oat1 and Oat3 in ANIT-treated rats, whereas, the mRNA levels of Oat1, Oat3 and Mrp2 were up-regulated with a concomitant increase in urinary BIL after treatment with JBP485 in ANIT-treated rats. Conclusion: JBP485 improved liver inflammation condition induced by ANIT. The mechanism is related to decrease the inflammatory mediators release and improvement of the expression and function for Oat1, Oat3 and Mrp2 as well as facilitation of urinary excretion for hepatoxic substance. JBP485 might be a good candidate for a new therapeutic agent for cholestatic hepatitis. Background: To study the effects of bone marrow mesenchymal stem cells (BM MSCs) allograft on the recovery of ischemic reperfusion injury and tight junction of intestine in rats.
Methods:
(1) BM MSCs were isolated from femur of male Wistar rats by the density gradient centrifugation, the third generation cultured cells were prepared as suspension.
(2) Intestinal ischemic reperfusion injury models were established in male Wistar rats, which were divided into the experimental group (1 ml BM MSCs suspention was injected into the intestinal submucosa) and the control group (1 ml saline was inject into the intestinal submucosa). Then, serum and intestinal tissue samples were collected at different time after injection, which were analyzed by luciferase tracing, immunohistochemistry, ELISA, transmission electron microscope and Western Blot. Results: BM MSCs were isolated and cultured successfully with high purity and homogeneity, and intestinal ischemic reperfusion injury models were established successfully. 
